Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04704193 · ClinicalTrials.gov registry record · NA
Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT04704193: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04704193 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04704193, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
An electronic decision aid will be used to assist individuals in choosing a multi-gene panel with their medical oncologist instead of a genetic counselor. A decision aid may facilitate quality decisions around the selection of a specific multi-gene panel without a genetic counselor. Upon completion of the decision aid, participants will be asked to indicate their decision about whether to pursue genetic testing and which specific multi-gene panel to pursue. A survey will then be administered to assess participants' opinions on the decision aid.
Interventions
- OTHER Survey of Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2020-11-20 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04704193
The ClinicalTrials.gov registry entry for NCT04704193 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Survey of Decision Aid is the first listed.
NCT04704193 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04704193 about?
NCT04704193 is a clinical study titled "Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes". An electronic decision aid will be used to assist individuals in choosing a multi-gene panel with their medical oncologist instead of a genetic counselor. A decision aid may facilitate quality decisions around the selection of a specific multi-gene panel without a genetic counselor. Upon completion ...
What is the current status of trial NCT04704193?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2020-11-20. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04704193?
The interventions under investigation include: Survey of Decision Aid (OTHER).
Who is sponsoring clinical trial NCT04704193?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.